Laboratory Medicine ›› 2018, Vol. 33 ›› Issue (8): 711-715.DOI: 10.3969/j.issn.1673-8640.2018.08.010
• Orginal Article • Previous Articles Next Articles
WANG Xiaolong, HUANG Zuofu, ZHANG Shuxia, YANG Yulin
Received:
2017-08-31
Online:
2018-08-10
Published:
2018-09-07
WANG Xiaolong, HUANG Zuofu, ZHANG Shuxia, YANG Yulin. Bloodstream infection and pathogen drug resistance in hemodialysis patients[J]. Laboratory Medicine, 2018, 33(8): 711-715.
Add to citation manager EndNote|Ris|BibTeX
URL: https://www.shjyyx.com/EN/10.3969/j.issn.1673-8640.2018.08.010
病原菌 | 2013年 | 2014年 | 2015年 | 2016年 | 合计 | 构成比(%) |
---|---|---|---|---|---|---|
革兰阳性球菌 | ||||||
金黄色葡萄球菌 | 1 | 7 | 16 | 11 | 35 | 40.7 |
表皮葡萄球菌 | 0 | 1 | 3 | 2 | 6 | 7.0 |
人葡萄球菌 | 1 | 0 | 2 | 1 | 4 | 4.7 |
山羊葡萄球菌 | 1 | 0 | 1 | 0 | 2 | 2.3 |
革兰阴性杆菌 | ||||||
大肠埃希菌 | 3 | 3 | 3 | 7 | 16 | 18.6 |
铜绿假单胞菌 | 2 | 3 | 1 | 0 | 6 | 7.0 |
肺炎克雷伯菌 | 2 | 0 | 2 | 2 | 6 | 7.0 |
普通变形杆菌 | 0 | 1 | 0 | 0 | 1 | 1.2 |
摩根氏摩根菌 | 0 | 1 | 0 | 0 | 1 | 1.2 |
阴沟肠杆菌 | 1 | 0 | 0 | 0 | 1 | 1.2 |
溶血不动杆菌 | 0 | 0 | 1 | 0 | 1 | 1.2 |
酵母样真菌 | ||||||
白假丝酵母 | 0 | 1 | 0 | 2 | 3 | 3.5 |
近平滑假丝酵母 | 0 | 1 | 0 | 2 | 3 | 3.5 |
热带假丝酵母 | 0 | 0 | 0 | 1 | 1 | 1.2 |
合计 | 11 | 18 | 29 | 28 | 86 | 100.0 |
病原菌 | 2013年 | 2014年 | 2015年 | 2016年 | 合计 | 构成比(%) |
---|---|---|---|---|---|---|
革兰阳性球菌 | ||||||
金黄色葡萄球菌 | 1 | 7 | 16 | 11 | 35 | 40.7 |
表皮葡萄球菌 | 0 | 1 | 3 | 2 | 6 | 7.0 |
人葡萄球菌 | 1 | 0 | 2 | 1 | 4 | 4.7 |
山羊葡萄球菌 | 1 | 0 | 1 | 0 | 2 | 2.3 |
革兰阴性杆菌 | ||||||
大肠埃希菌 | 3 | 3 | 3 | 7 | 16 | 18.6 |
铜绿假单胞菌 | 2 | 3 | 1 | 0 | 6 | 7.0 |
肺炎克雷伯菌 | 2 | 0 | 2 | 2 | 6 | 7.0 |
普通变形杆菌 | 0 | 1 | 0 | 0 | 1 | 1.2 |
摩根氏摩根菌 | 0 | 1 | 0 | 0 | 1 | 1.2 |
阴沟肠杆菌 | 1 | 0 | 0 | 0 | 1 | 1.2 |
溶血不动杆菌 | 0 | 0 | 1 | 0 | 1 | 1.2 |
酵母样真菌 | ||||||
白假丝酵母 | 0 | 1 | 0 | 2 | 3 | 3.5 |
近平滑假丝酵母 | 0 | 1 | 0 | 2 | 3 | 3.5 |
热带假丝酵母 | 0 | 0 | 0 | 1 | 1 | 1.2 |
合计 | 11 | 18 | 29 | 28 | 86 | 100.0 |
抗菌药物 | 金黄色葡萄球菌(35例) | 凝固酶阴性葡萄球菌 | 合计(47例) | |
---|---|---|---|---|
表皮葡萄球菌(6例) | 其他(6例) | |||
万古霉素 | 100.0(35) | 100.0(6) | 100.0(6) | 100.0(47) |
利奈唑胺 | 100.0(35) | 100.0(6) | 100.0(6) | 100.0(47) |
达托霉素 | 100.0(35) | 100.0(6) | 88.3(5) | 97.9(46) |
喹奴普丁-达福普丁 | 100.0(35) | 100.0(6) | 88.3(5) | 97.9(46) |
利福平 | 94.3(33) | 100.0(6) | 88.3(5) | 93.6(44) |
四环素 | 82.9(29) | 100.0(6) | 100.0(6) | 87.2(41) |
左氧氟沙星 | 88.6(31) | 16.7(1) | 66.7(4) | 76.6(36) |
庆大霉素 | 77.1(27) | 66.7(4) | 66.7(4) | 74.5(35) |
莫西沙星 | 88.6(31) | 16.7(1) | 33.3(2) | 72.3(34) |
环丙沙星 | 82.9(29) | 16.7(1) | 50.0(3) | 70.2(33) |
复方磺胺甲噁唑 | 71.4(25) | 33.3(2) | 88.3(5) | 68.1(32) |
克林霉素 | 60.0(21) | 66.7(4) | 66.7(4) | 61.7(29) |
红霉素 | 40.0(14) | 50.0(3) | 50.0(3) | 42.6(20) |
青霉素 | 0.0(0) | 16.7(1) | 0.0(0) | 2.1(1) |
抗菌药物 | 金黄色葡萄球菌(35例) | 凝固酶阴性葡萄球菌 | 合计(47例) | |
---|---|---|---|---|
表皮葡萄球菌(6例) | 其他(6例) | |||
万古霉素 | 100.0(35) | 100.0(6) | 100.0(6) | 100.0(47) |
利奈唑胺 | 100.0(35) | 100.0(6) | 100.0(6) | 100.0(47) |
达托霉素 | 100.0(35) | 100.0(6) | 88.3(5) | 97.9(46) |
喹奴普丁-达福普丁 | 100.0(35) | 100.0(6) | 88.3(5) | 97.9(46) |
利福平 | 94.3(33) | 100.0(6) | 88.3(5) | 93.6(44) |
四环素 | 82.9(29) | 100.0(6) | 100.0(6) | 87.2(41) |
左氧氟沙星 | 88.6(31) | 16.7(1) | 66.7(4) | 76.6(36) |
庆大霉素 | 77.1(27) | 66.7(4) | 66.7(4) | 74.5(35) |
莫西沙星 | 88.6(31) | 16.7(1) | 33.3(2) | 72.3(34) |
环丙沙星 | 82.9(29) | 16.7(1) | 50.0(3) | 70.2(33) |
复方磺胺甲噁唑 | 71.4(25) | 33.3(2) | 88.3(5) | 68.1(32) |
克林霉素 | 60.0(21) | 66.7(4) | 66.7(4) | 61.7(29) |
红霉素 | 40.0(14) | 50.0(3) | 50.0(3) | 42.6(20) |
青霉素 | 0.0(0) | 16.7(1) | 0.0(0) | 2.1(1) |
抗菌药物 | 大肠埃希菌 (16例) | 铜绿假单胞菌 (6例) | 肺炎克雷伯菌 (6例) | 其他革兰阴性杆菌 (4例) | 合计(32例) |
---|---|---|---|---|---|
阿米卡星 | 100.0(16) | 100.0(6) | 100.0(6) | 100.0(4) | 100.0(32) |
美罗培南 | 100.0(16) | 100.0(6) | 100.0(6) | 100.0(4) | 100.0(32) |
哌拉西林-他唑巴坦 | 100.0(16) | 83.3(5) | 100.0(6) | 100.0(4) | 96.9(31) |
亚胺培南 | 100.0(16) | 66.7(4) | 100.0(6) | 75.0(3) | 90.6(29) |
头孢吡肟 | 75.0(12) | 100.0(6) | 100.0(6) | 100.0(4) | 87.5(28) |
头孢替坦 | 100.0(16) | 66.7(4) | 100.0(6) | 50.0(2) | 87.5(28) |
厄他培南 | 100.0(16) | 100.0(6) | 100.0(4) | 81.3(26) | |
氨曲南 | 62.5(10) | 100.0(6) | 100.0(6) | 75.0(3) | 78.1(25) |
环丙沙星 | 50.0(8) | 100.0(6) | 100.0(6) | 100.0(4) | 75.0(24) |
头孢他啶 | 62.5(10) | 100.0(6) | 100.0(6) | 50.0(2) | 75.0(24) |
妥布霉素 | 50.0(8) | 100.0(6) | 100.0(6) | 50.0(2) | 68.8(22) |
庆大霉素 | 56.3(9) | 100.0(6) | 100.0(6) | 25.0(1) | 68.8(22) |
左氧氟沙星 | 50.0(8) | 83.3(5) | 100.0(6) | 50.0(2) | 65.6(21) |
复方磺胺甲噁唑 | 56.3(9) | 100.0(6) | 100.0(4) | 59.4(19) | |
头孢唑啉 | 37.5(6) | 100.0(6) | 50.0(2) | 43.8(14) | |
头孢曲松 | 43.8(7) | 100.0(6) | 25.0(1) | 43.8(14) | |
氨苄西林-舒巴坦 | 31.3(5) | 100.0(6) | 25.0(1) | 37.5(12) | |
氨苄西林 | 6.3(1) | 25.0(1) | 6.3(2) |
抗菌药物 | 大肠埃希菌 (16例) | 铜绿假单胞菌 (6例) | 肺炎克雷伯菌 (6例) | 其他革兰阴性杆菌 (4例) | 合计(32例) |
---|---|---|---|---|---|
阿米卡星 | 100.0(16) | 100.0(6) | 100.0(6) | 100.0(4) | 100.0(32) |
美罗培南 | 100.0(16) | 100.0(6) | 100.0(6) | 100.0(4) | 100.0(32) |
哌拉西林-他唑巴坦 | 100.0(16) | 83.3(5) | 100.0(6) | 100.0(4) | 96.9(31) |
亚胺培南 | 100.0(16) | 66.7(4) | 100.0(6) | 75.0(3) | 90.6(29) |
头孢吡肟 | 75.0(12) | 100.0(6) | 100.0(6) | 100.0(4) | 87.5(28) |
头孢替坦 | 100.0(16) | 66.7(4) | 100.0(6) | 50.0(2) | 87.5(28) |
厄他培南 | 100.0(16) | 100.0(6) | 100.0(4) | 81.3(26) | |
氨曲南 | 62.5(10) | 100.0(6) | 100.0(6) | 75.0(3) | 78.1(25) |
环丙沙星 | 50.0(8) | 100.0(6) | 100.0(6) | 100.0(4) | 75.0(24) |
头孢他啶 | 62.5(10) | 100.0(6) | 100.0(6) | 50.0(2) | 75.0(24) |
妥布霉素 | 50.0(8) | 100.0(6) | 100.0(6) | 50.0(2) | 68.8(22) |
庆大霉素 | 56.3(9) | 100.0(6) | 100.0(6) | 25.0(1) | 68.8(22) |
左氧氟沙星 | 50.0(8) | 83.3(5) | 100.0(6) | 50.0(2) | 65.6(21) |
复方磺胺甲噁唑 | 56.3(9) | 100.0(6) | 100.0(4) | 59.4(19) | |
头孢唑啉 | 37.5(6) | 100.0(6) | 50.0(2) | 43.8(14) | |
头孢曲松 | 43.8(7) | 100.0(6) | 25.0(1) | 43.8(14) | |
氨苄西林-舒巴坦 | 31.3(5) | 100.0(6) | 25.0(1) | 37.5(12) | |
氨苄西林 | 6.3(1) | 25.0(1) | 6.3(2) |
抗菌药物 | 革兰阳性球菌(47例) | 革兰阴性杆菌(32例) | χ2值 | P值 |
---|---|---|---|---|
庆大霉素 | 74.5(35) | 68.8(22) | 0.310 | 0.578 |
左氧氟沙星 | 76.6(36) | 65.6(21) | 1.140 | 0.286 |
环丙沙星 | 70.2(33) | 75.0(24) | 0.217 | 0.641 |
复方磺胺甲噁唑 | 68.1(32) | 59.4(19) | 0.631 | 0.427 |
抗菌药物 | 革兰阳性球菌(47例) | 革兰阴性杆菌(32例) | χ2值 | P值 |
---|---|---|---|---|
庆大霉素 | 74.5(35) | 68.8(22) | 0.310 | 0.578 |
左氧氟沙星 | 76.6(36) | 65.6(21) | 1.140 | 0.286 |
环丙沙星 | 70.2(33) | 75.0(24) | 0.217 | 0.641 |
复方磺胺甲噁唑 | 68.1(32) | 59.4(19) | 0.631 | 0.427 |
[1] | 王艳艳. 老年肾功能衰竭患者血液透析的疗效观察[J]. 临床合理用药杂志,2016,9(5):102-103. |
[2] | 孟令栋,刘昌华,伍刚. 慢性肾脏病研究进展[J]. 山西医药杂志,2017,46(10):1170-1172. |
[3] | SAHA M,ALLON M.Diagnosis,treatment,and prevention of hemodialysis emergencies[J]. Clin J Am Soc Nephrol,2017,12(2):357-369. |
[4] | 顾峰. 维持性血液透析患者心血管疾病死亡的危险因素分析[J]. 检验医学,2017,32(6):486-489. |
[5] | MUREA M,JAMES KM,RUSSELL G B,et al.Risk of catheter-related bloodstream infection in elderly patients on hemodialysis[J]. Clin J Am Soc Nephrol,2014,9(4):764-770. |
[6] | 张丽萍,付阿丹,朱江,等. 血液透析患者导管相关性血流感染风险评估研究[J]. 中华医院感染学杂志,2015,25(23):5421-5423. |
[7] | 马建波,戴金华,余秋云,等. 腹膜透析液病原学监测及耐药情况分析[J]. 检验医学,2012,27(6):509-511. |
[8] | MOORE C L,BESARAB A,AJLUNI M,et al.Comparative effectiveness of two catheter locking solutions to reduce catheter-related bloodstream infection in hemodialysis patients[J]. Clin J Am Soc Nephrol,2014,9(7):1232-1239. |
[9] | COLLIER S,KANDIL H,YEWNETU E,et al.Infection rates following buttonhole cannulation in hemodialysis patients[J]. Ther Apher Dial,2016,20(5):476-482. |
[10] | 李月婷,车丽双,黄荣桂. 血液透析导管相关性血流感染的病原学分析[J]. 中华医院感染学杂志,2015,25(12):2707-2708. |
[11] | 楼宏青,金云燕,许桂军. 血液透析患者导管相关性血流感染病原菌分布及耐药性分析[J]. 中华医院感染学杂志,2014,24(12):2891-2892. |
[12] | VASUDEV R,SHAH P,KAUR S,et al.Infective endocarditis in hemodialysis patients[J]. J Heart Valve Dis,2016,25(3):369-374. |
[13] | FRAM D,OKUNO M F,TAMINATO M,et al.Risk factors for bloodstream infection in patients at a Brazilian hemodialysis center:a case-control study[J]. BMC Infect Dis,2015, 15:158. |
[14] | 郭健莲,肖斌龙,刘惠娜,等. 血培养报阳时间在鉴别血流感染和采血污染中的应用[J]. 中国感染控制杂志,2015,14(12):803-806. |
[15] | 赵艳春,胡必杰,吴安华,等. 全国多中心ICU抗菌药物使用与多药耐药菌监测分析[J]. 中华医院感染学杂志,2015,25(21):4867-4869. |
[16] | 国家卫生计生委合理用药专家委员会,全国细菌耐药监测网. 2015年全国细菌耐药监测报告[J]. 中国执业药师,2016,13(3):3-8. |
[1] | ZHAO Yanan, CAO Qixin, YAN Yan, LI Xiaocong, ZHAO Jianping, XIAO Weili. Research progress of CRISPR/Cas13 system for pathogen detection [J]. Laboratory Medicine, 2023, 38(8): 800-804. |
[2] | MA Kaihui, LÜ Zhi, ZHOU Yanyan, SU Jianrong. Characteristic analysis of Clostridium difficile colonization and infection in inpatients [J]. Laboratory Medicine, 2023, 38(2): 153-156. |
[3] | REN Yanfei, ZHANG Min, YANG Tao, LI Rongkai, LIANG Xin. Analysis of pathogenic epidemiology of patients with lower respiratory tract infection in respiratory intensive care unit [J]. Laboratory Medicine, 2023, 38(2): 157-162. |
[4] | TIAN Yuanyuan, JIA Xiongfei. Advantages and pathogenicity of Enterococci [J]. Laboratory Medicine, 2023, 38(11): 1101-1105. |
[5] | CHEN Hanlu, WU Shenghai. Influence factors of blood culture negative results and progress of pathogen detection in bloodstream infection [J]. Laboratory Medicine, 2022, 37(7): 688-694. |
[6] | WANG Jianying, WANG Shanshan, ZHU Jun, HUANG Xiaochun, WAN Yuxiang, LIU Yun. Distribution and drug resistance of respiratory infection pathogens in patients with lung cancer after chemotherapy [J]. Laboratory Medicine, 2022, 37(4): 356-359. |
[7] | GU Feng, WU Yanfen, ZHAO Xinhui, HOU Zhaoyuan, WANG Zhihong, QI Hualin. Relationship between procalcitonin level and all-cause death in maintenance hemodialysis patients [J]. Laboratory Medicine, 2022, 37(2): 134-140. |
[8] | PAN Yunqi, LI Yungai, WANG Jianqiang, WU Qiong, TANG Jin. Analysis of molecular typing,virulence genes and antibiotic susceptibility of uropathogenic Escherichia coli in patients with recurrent urinary tract infection [J]. Laboratory Medicine, 2022, 37(2): 141-145. |
[9] | KANG Yi, ZHU Hong, SHEN Han, ZHOU Wanqing. Virulence gene analysis of Enterococcus isolated from clinical blood and urine samples [J]. Laboratory Medicine, 2022, 37(11): 1030-1033. |
[10] | LIU Hongqian, SONG Chaohui, LIANG Qiaomi. Establishment and clinical application of multiple RT-PCR MassARRAY for the determinations of 27 respiratory pathogens [J]. Laboratory Medicine, 2021, 36(9): 939-946. |
[11] | HE Ping'an, LU Yanzhou, YANG Xu, LÜ Mei, XIA Qing, LI Qingrong. Research progress in burn infection pathogens and drug resistance with the length of stay during hospitalization [J]. Laboratory Medicine, 2021, 36(9): 973-975. |
[12] | WANG Bowen, ZENG Xiaohua, PENG Kaige, LIU Chang, WU Yingchao, HUANG Yingmei, MA Panpan, Lamuciren , LI Guokai, YANG Li. Influence of different inactivating conditions on nucleic acid determination for respiratory pathogens [J]. Laboratory Medicine, 2021, 36(8): 805-808. |
[13] | QIAN Xiangbei, WU Zhiming. Correlation of serum magnesium level with body composition and survival in hemodialysis patients [J]. Laboratory Medicine, 2021, 36(8): 823-827. |
[14] | YU Jiajia, LI Yuanrui, LIU Ying. MALDI-TOF MS combined with SDS and SAP pretreatment for rapid identification of positive blood culture [J]. Laboratory Medicine, 2021, 36(8): 864-868. |
[15] | ZHAO Yanan, CAO Qixin, ZHAO Jianping. Role of time to positive of blood culturing in preliminary microbial identification [J]. Laboratory Medicine, 2021, 36(12): 1210-1214. |
Viewed | ||||||
Full text |
|
|||||
Abstract |
|
|||||